Current Strategies to Enhance Adipose Stem Cell Function: An Update

Mesenchymal stem cells (MSCs) emerged as a promising therapeutic tool targeting a variety of inflammatory disorders due to their multiple remarkable properties, such as superior immunomodulatory function and tissue-regenerative capacity. Although bone marrow (BM) is a dominant source for adult MSCs,...

Full description

Bibliographic Details
Main Authors: Yoojin Seo, Tae-Hoon Shin, Hyung-Sik Kim
Format: Article
Language:English
Published: MDPI AG 2019-08-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/20/15/3827
_version_ 1811322296927780864
author Yoojin Seo
Tae-Hoon Shin
Hyung-Sik Kim
author_facet Yoojin Seo
Tae-Hoon Shin
Hyung-Sik Kim
author_sort Yoojin Seo
collection DOAJ
description Mesenchymal stem cells (MSCs) emerged as a promising therapeutic tool targeting a variety of inflammatory disorders due to their multiple remarkable properties, such as superior immunomodulatory function and tissue-regenerative capacity. Although bone marrow (BM) is a dominant source for adult MSCs, increasing evidence suggests that adipose tissue-derived stem cells (ASCs), which can be easily obtained at a relatively high yield, have potent therapeutic advantages comparable with BM-MSCs. Despite its outstanding benefits in pre-clinical settings, the practical efficacy of ASCs remains controversial since clinical trials with ASC application often resulted in unsatisfactory outcomes. To overcome this challenge, scientists established several strategies to generate highly functional ASCs beyond the naïve cells, including (1) pre-conditioning of ASCs with various stimulants such as inflammatory agents, (2) genetic manipulation of ASCs and (3) modification of culture conditions with three-dimensional (3D) aggregate formation and hypoxic culture. Also, exosomes and other extracellular vesicles secreted from ASCs can be applied directly to recapitulate the beneficial performance of ASCs. This review summarizes the current strategies to improve the therapeutic features of ASCs for successful clinical implementation.
first_indexed 2024-04-13T13:32:39Z
format Article
id doaj.art-76d59bd4b0c44b75b1efb04589b4306c
institution Directory Open Access Journal
issn 1422-0067
language English
last_indexed 2024-04-13T13:32:39Z
publishDate 2019-08-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-76d59bd4b0c44b75b1efb04589b4306c2022-12-22T02:44:54ZengMDPI AGInternational Journal of Molecular Sciences1422-00672019-08-012015382710.3390/ijms20153827ijms20153827Current Strategies to Enhance Adipose Stem Cell Function: An UpdateYoojin Seo0Tae-Hoon Shin1Hyung-Sik Kim2Dental and Life Science Institute, Pusan National University, Yangsan 50612, KoreaTranslational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USADental and Life Science Institute, Pusan National University, Yangsan 50612, KoreaMesenchymal stem cells (MSCs) emerged as a promising therapeutic tool targeting a variety of inflammatory disorders due to their multiple remarkable properties, such as superior immunomodulatory function and tissue-regenerative capacity. Although bone marrow (BM) is a dominant source for adult MSCs, increasing evidence suggests that adipose tissue-derived stem cells (ASCs), which can be easily obtained at a relatively high yield, have potent therapeutic advantages comparable with BM-MSCs. Despite its outstanding benefits in pre-clinical settings, the practical efficacy of ASCs remains controversial since clinical trials with ASC application often resulted in unsatisfactory outcomes. To overcome this challenge, scientists established several strategies to generate highly functional ASCs beyond the naïve cells, including (1) pre-conditioning of ASCs with various stimulants such as inflammatory agents, (2) genetic manipulation of ASCs and (3) modification of culture conditions with three-dimensional (3D) aggregate formation and hypoxic culture. Also, exosomes and other extracellular vesicles secreted from ASCs can be applied directly to recapitulate the beneficial performance of ASCs. This review summarizes the current strategies to improve the therapeutic features of ASCs for successful clinical implementation.https://www.mdpi.com/1422-0067/20/15/3827adipose stem cellsmesenchymal stem cellsimmunomodulationcell therapyfunction enhancement
spellingShingle Yoojin Seo
Tae-Hoon Shin
Hyung-Sik Kim
Current Strategies to Enhance Adipose Stem Cell Function: An Update
International Journal of Molecular Sciences
adipose stem cells
mesenchymal stem cells
immunomodulation
cell therapy
function enhancement
title Current Strategies to Enhance Adipose Stem Cell Function: An Update
title_full Current Strategies to Enhance Adipose Stem Cell Function: An Update
title_fullStr Current Strategies to Enhance Adipose Stem Cell Function: An Update
title_full_unstemmed Current Strategies to Enhance Adipose Stem Cell Function: An Update
title_short Current Strategies to Enhance Adipose Stem Cell Function: An Update
title_sort current strategies to enhance adipose stem cell function an update
topic adipose stem cells
mesenchymal stem cells
immunomodulation
cell therapy
function enhancement
url https://www.mdpi.com/1422-0067/20/15/3827
work_keys_str_mv AT yoojinseo currentstrategiestoenhanceadiposestemcellfunctionanupdate
AT taehoonshin currentstrategiestoenhanceadiposestemcellfunctionanupdate
AT hyungsikkim currentstrategiestoenhanceadiposestemcellfunctionanupdate